Navigation Links
Nerve Conduction Studies Safe for Patients with Implanted Cardiac Devices

Patients with implanted cardiac devices and their physicians sometimes defer important electrodiagnostic testing because of anxiety about potential negative effects// the testing may have on the device. Good news for these patients and physicians is that according to recent research, electrodiagnostic testing was found to pose minimal or no risk to patients with implanted cardiac devices such as permanent pacemakers and implanted cardiac defibrillators.

Nerve conduction studies (NCSs) are done to detect and evaluate damage to the peripheral nervous system, which includes all the nerves that lead away from the brain and spinal cord and the smaller nerves that branch out from those nerves. Nerve conduction studies are often used to help diagnose nerve disorders, such as carpal tunnel syndrome or Guillain-Barre syndrome, and find the location of abnormal sensations, such as numbness, tingling, or pain.

The prevailing view among electrodiagnostic physicians and cardiac electrophysiologists, is that electrodiagnostic testing on patients with implanted cardiac devices is safe as long as the electrical stimulation is not given in direct proximity to the pulse generator of the cardiac device. Recording from intracardiac sensing electrodes during NCSs, which has not been previously reported, would be the best test to assess safety.

In a recent study, 10 patients with permanent bipolar pacemakers of various makes and 5 patients with implanted cardiac defibrillators (ICD) underwent nerve stimulation at sites commonly used during NCSs. The electrical impulses generated during routine NCSs were never detected by the sensing amplifier of the pacemaker or defibrillators. The NCS did not affect the programmed pacemaker or defibrillator settings and did not cause the defibrillator to discharge. The pacemaker and defibrillator were interrogated before and after NCSs and surface electrocardiogram and atrial and ventricular electrograms were continuo usly monitored during NCSs.

The research concluded that routine NCSs are safe in patients with implanted cardiac pacemakers and defibrillators with bipolar sensing configurations.

Source-Newswise
'"/>




Related medicine news :

1. Epilepsy Drug Helps Diabetic Nerve Damage
2. World’s First Nerve Stem Cells Produced
3. Children With Epilepsy Can Be Treated With Nerve Stimulation
4. FDA Approved Nerve-Stimulation Therapy Now Available In New York
5. Doctors Finish Mother-To-Son Nerve Surgery
6. Stem Cells From Hair Follicle To Repair Nerve Damage
7. Nerve regeneration for Spinal cord injuries
8. Novel Protein, Staufen2 Important In Maintenance Of Nerve Synapses
9. Dividing Nerve Cells Could Trigger Alzheimers Disease
10. Protein Found to Be Essential For Maintaining Nerve Health
11. Nerve Stimulator for Depression Though Not Effective Was Given Approval
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... Braunfels, TX (PRWEB) , ... March 23, 2017 , ... ... new clinic, located at 960 Gruene Road in Building 2. The clinic is the ... Dr. Andrew Bennett, PT, says opening the company’s second New Braunfels location brings things ...
(Date:3/23/2017)... ... ... The IoT (Internet of Things) is revolutionizing the way the world operates. ... and individual consumers alike. Laboratories can maximize their profit margin by increasing throughput. ... trillion to $11 trillion dollars by the year 2025. McKinsey expects the IoT to ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... 82% of adults are unaware of the ... do not brush their teeth the minimum two times a day that dentists recommend. The ... missing 51 million hours of school and adults missing 164 million hours of work each ...
(Date:3/23/2017)... ... ... March is National Kidney Month – the perfect time to pause and ... health. Every day, two kidneys filter about 120 to 150 quarts of blood. Put ... waste, regulating fluid levels and blood pressure, supporting bone health and promoting red blood ...
(Date:3/23/2017)... ... March 23, 2017 , ... The StayWell Company announced today ... accreditation covers StayWell’s asthma, coronary artery disease, congestive heart failure, chronic obstructive pulmonary ... have excellent programs for the delivery and improvement of disease management and that ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... DUBLIN , Mar 23, 2017 Research ... Electrophoresis Market 2017-2021" report to their offering. ... The global capillary electrophoresis market ... The report, Global Capillary Electrophoresis Market 2017-2021, has ... industry experts. The report covers the market landscape and its growth ...
(Date:3/23/2017)... -- CENTRO DE IMAGEM DIAGNOSTICOS S.A. (" Company "), ... 6,404/76 and Instruction 358/02 of the Brazilian Securities and ... market in general that it entered yesterday, as a ... Imagem Ltda. (" CDI "), into an agreement for ... (" Partnership " and " Acquisition "). ...
(Date:3/23/2017)... -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company ... unmet medical needs in rare diseases, today announced that ... on Monday, April 3 during ENDO 2017, the annual ... Florida , to discuss new data regarding its ... PTH and TransCon CNP). Ascendis is presenting ...
Breaking Medicine Technology: